Circio Holding ASA (LTS:0RIS) Other Current Receivables: kr4.46 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RIS Circio Holding ASA LTS:0RIS
23 GF Score
Price kr8.51
! 3 Warning Signs
View Full Analysis

What is Circio Holding ASA Other Current Receivables?

Circio Holding ASA LTS:0RIS +4.29% 23 Other Current Receivables is kr4.46 Mil as of Dec. 2025. GuruFocus rates LTS:0RIS with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

Circio Holding ASA's Other Current Receivables for the quarter that ended in Dec. 2025 was kr4.46 Mil.

Circio Holding ASA's quarterly Other Current Receivables declined from Dec. 2024 (kr3.31 Mil) to Jun. 2025 (kr0.00 Mil) but then increased from Jun. 2025 (kr0.00 Mil) to Dec. 2025 (kr4.46 Mil).

Circio Holding ASA's annual Other Current Receivables declined from Dec. 2023 (kr3.45 Mil) to Dec. 2024 (kr3.31 Mil) but then increased from Dec. 2024 (kr3.31 Mil) to Dec. 2025 (kr4.46 Mil).

Circio Holding ASA Other Current Receivables Related Terms

Circio Holding ASA Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Circio Holding ASA's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Circio Holding ASA Other Current Receivables Chart

Circio Holding ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.01 20.63 3.45 3.31 4.46

Circio Holding ASA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.45 0.00 3.31 0.00 4.46
LTS:0RIS
23GF Score
Circio Holding ASA LTS:0RIS
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Circio Holding ASA Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of kr4.46 Mil mean?
Circio Holding ASA (LTS:0RIS) has a Other Current Receivables of kr4.46 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Circio Holding ASA and its competitors.
Is Circio Holding ASA's Other Current Receivables too high?
Circio Holding ASA's current Other Current Receivables is kr4.46 Mil. Overall, Circio Holding ASA has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Circio Holding ASA's Other Current Receivables compare to VRTX and REGN?
Circio Holding ASA's Other Current Receivables of kr4.46 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Circio Holding ASA and its competitors. Circio Holding ASA's current Other Current Receivables is kr4.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Circio Holding ASA stock overvalued right now?
Circio Holding ASA (LTS:0RIS) has a current Other Current Receivables of kr4.46 Mil. The current Other Current Receivables is kr4.46 Mil. Circio Holding ASA's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Circio Holding ASA (LTS:0RIS), the current Other Current Receivables is kr4.46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Circio Holding ASA Business Description

Other Exchanges CRNA:NorwayTA50:Germany
Address c/o Mesh Community AS, Tordenskiolds Gate 2, Oslo, NOR, 0160
Circio Holding ASA is a biotechnology company developing circular RNA expression technology for gene and cell therapy applications. It has developed a circular RNA (circRNA) vector expression platform known as circVec, which is based on modular genetic constructs designed for circRNA production within target cells. The platform is being developed for applications including genetic medicine, cell therapy, and chronic disease treatment. The company's activities also include the development of RNA, DNA, and viral therapeutic technologies related to gene expression and protein production.
23GF Score

Get the complete analysis for LTS:0RIS

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.51
Price